Here's the live share price of Emcure Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Emcure Pharmaceuticals | -5.59 | -4.19 | 1.50 | 14.55 | 31.47 | 10.53 | 6.19 |
| Sun Pharmaceutical Industries | -2.93 | -5.97 | -9.38 | 2.30 | 5.94 | 16.08 | 16.11 |
| Divi's Laboratories | 0.34 | -1.65 | 36.92 | 56.54 | 52.09 | 36.06 | 12.63 |
| Torrent Pharmaceuticals | -2.14 | -5.51 | -4.83 | 13.85 | 31.30 | 35.10 | 24.08 |
| Zydus Lifesciences | -2.63 | -1.23 | -3.86 | 23.60 | 11.95 | 22.90 | 15.27 |
| Laurus Labs | 2.17 | 5.11 | 35.18 | 87.55 | 134.26 | 72.17 | 26.01 |
| Cipla | -3.23 | -4.73 | -9.60 | 6.46 | -13.83 | 3.97 | 7.36 |
| Dr. Reddy's Laboratories | -0.42 | 4.54 | -5.88 | -1.42 | -4.06 | 2.83 | 4.08 |
| Mankind Pharma | -6.13 | 4.69 | -6.29 | 15.49 | -4.33 | 10.24 | 10.75 |
| Aurobindo Pharma | 0.66 | -0.23 | 6.28 | 25.88 | 50.69 | 22.80 | 18.54 |
| Lupin | -3.40 | -6.31 | -21.69 | -14.64 | 0.13 | 19.47 | 15.37 |
| Glenmark Pharmaceuticals | -1.93 | -6.08 | 1.15 | 5.63 | 18.37 | 42.93 | 33.83 |
| Alkem Laboratories | 0.42 | 2.37 | -6.83 | -2.00 | -3.91 | 14.03 | 6.03 |
| Biocon | -6.04 | -11.77 | -13.66 | 0.80 | -1.20 | 10.18 | -0.65 |
| Abbott India | -3.18 | 3.00 | -2.93 | 0.70 | -12.46 | 4.20 | 3.35 |
| Gland Pharma | 6.56 | 1.23 | 24.02 | 75.38 | 56.63 | 23.65 | -4.28 |
| Anthem Biosciences | 1.13 | -8.47 | 14.96 | 19.88 | 11.77 | 5.75 | 3.41 |
| Ipca Laboratories | -1.56 | -2.73 | 7.80 | 31.74 | 42.72 | 26.85 | 10.14 |
| GlaxoSmithKline Pharmaceuticals | -8.63 | -12.17 | 3.76 | 7.40 | -8.11 | 18.00 | 11.41 |
| Ajanta Pharma | -4.89 | -3.74 | 3.08 | 23.89 | 40.69 | 25.01 | 17.29 |
Source: Dion Global
Over the last one year, Emcure Pharmaceuticals has gained 31.47% compared to peers like Sun Pharmaceutical Industries (5.94%), Divi's Laboratories (52.09%), Torrent Pharmaceuticals (31.30%). From a 5 year perspective, Emcure Pharmaceuticals has underperformed peers relative to Sun Pharmaceutical Industries (16.11%) and Divi's Laboratories (12.63%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,932.73 | 1,930.35 |
| 10 | 1,942.81 | 1,938.58 |
| 20 | 1,951.73 | 1,938.53 |
| 50 | 1,928.73 | 1,912.65 |
| 100 | 1,854.55 | 1,846.43 |
| 200 | 1,690.36 | 1,727.39 |
Source: Dion Global
In the latest quarter, Emcure Pharmaceuticals saw a drop in promoter holding to 77.83%, while DII stake increased to 8.46%, FII holding rose to 4.87%, and public shareholding moved down to 8.84% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 43,15,000 | 1.12 | 800.56 | |
| 16,29,733 | 0.54 | 302.36 | |
| 13,49,941 | 1.72 | 250.45 | |
| 11,28,993 | 0.9 | 209.46 | |
| 8,84,772 | 0.86 | 164.15 | |
| 8,14,919 | 0.48 | 151.19 | |
| 6,40,910 | 1.25 | 118.91 | |
| 4,39,742 | 1.08 | 81.59 | |
| 3,93,680 | 1.17 | 73.04 | |
| 2,75,555 | 0.85 | 51.12 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Oct 03, 2026, 02:59 AM IST IST | Emcure Pharma. - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order |
| Sep 25, 2026, 10:06 PM IST IST | Emcure Pharma. - Announcement under Regulation 30 (LODR)-Investor Presentation |
| Sep 23, 2026, 11:58 PM IST IST | Emcure Pharma. - Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirement) Regulations, 2015 |
| Sep 23, 2026, 11:44 PM IST IST | Emcure Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| Sep 22, 2026, 12:30 AM IST IST | Emcure Pharma. - Shareholder Meeting / Postal Ballot-Outcome of AGM |
Source: Dion Global
Emcure Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 16/04/1981 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24231PN1981PLC024251 and registration number is 024251. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 5243.19 Cr. and Equity Capital is Rs. 189.59 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Emcure Pharmaceuticals is ₹1,835.00 as on Oct 09, 2026.
The Emcure Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
The market cap of Emcure Pharmaceuticals is ₹34,811.90 Cr as on Oct 09, 2026.
Today’s highest and lowest price of Emcure Pharmaceuticals are ₹1,889.10 and ₹1,816.55.
The 52-week high/low is the highest and lowest price at which Emcure Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Emcure Pharmaceuticals is ₹2,101.00 and 52-week low of Emcure Pharmaceuticals is ₹1,307.50 as on Oct 09, 2026.
The Emcure Pharmaceuticals has shown returns of -0.88% over the past day, -4.19% for the past month, 1.5% over 3 months, 31.47% over 1 year, 10.53% across 3 years, and 6.19% over 5 years.
P/E ratio of and PB ratio of Emcure Pharmaceuticals are 34.42 and 6.64 on Oct 09, 2026. While the company gives a dividend yield of 0.20 per annum.
Source: Dion Global